Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
117M
-
Number of holders
-
197
-
Total 13F shares, excl. options
-
100M
-
Shares change
-
+5.81M
-
Total reported value, excl. options
-
$1.09B
-
Value change
-
+$61M
-
Put/Call ratio
-
0.97
-
Number of buys
-
93
-
Number of sells
-
-76
-
Price
-
$10.84
Significant Holders of DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) as of Q1 2022
235 filings reported holding DVAX - DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value as of Q1 2022.
DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) has 197 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 100M shares
of 117M outstanding shares and own 85.48% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (16.5M shares), STATE STREET CORP (8.5M shares), Bain Capital Life Sciences Investors, LLC (8.42M shares), BlackRock Inc. (7.79M shares), Chicago Capital, LLC (5.86M shares), VANGUARD GROUP INC (5.84M shares), PFM Health Sciences, LP (3.81M shares), Fisher Asset Management, LLC (3.51M shares), BLAIR WILLIAM & CO/IL (2.55M shares), and EDMOND DE ROTHSCHILD HOLDING S.A. (2.45M shares).
This table shows the top 197 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.